Infliximab for treating sarcoidosis patients, Portuguese experience;Infliximab no tratamento da sarcoidose - Experiência de um hospital central

Revista Portuguesa de Pneumologia

Volumn 17, Issue 2, 2011, Pages 85-93

  Aguiar, M ^a   Marcal N ^a   Mendes, A C ^a   Bugalho de Almeida, A ^a  

^a HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

Infliximab; Sarcoidosis

Indexed keywords

ACICLOVIR; ALLOPURINOL; ANTICOAGULANT AGENT; AZATHIOPRINE; BETA1A INTERFERON; CARBAMAZEPINE; CHLOROQUINE; COLCHICINE; CORTICOSTEROID; DEFLAZACORT; FLUCLOXACILLIN; HISTONE ANTIBODY; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; LIVER ENZYME; METHOTREXATE; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; STEROID; URIC ACID; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTHRALGIA; ARTICLE; ATAXIA; BIOPSY; BIPOLAR DISORDER; BRONCHIECTASIS; BRONCHUS BIOPSY; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORTICOSTEROID INDUCED OSTEOPOROSIS; COUGHING; CRANIOTOMY; DIABETES MELLITUS; DIPLOPIA; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG WITHDRAWAL; DYSARTHRIA; DYSPNEA; EPILEPSY; ESOPHAGUS VARICES; FACIAL NERVE PARALYSIS; FATIGUE; FEMALE; GOUT; GRANULOMA; GRANULOMATOUS INFLAMMATION; HEADACHE; HEPATOMEGALY; HEPATOSPLENOMEGALY; HERPES ZOSTER; HUMAN; HYPERNATREMIA; HYPERTENSION; HYPERURICEMIA; INTERVERTEBRAL DISK DEGENERATION; LACRIMAL GLAND; LAPAROSCOPIC SURGERY; LEUKOPENIA; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER TOXICITY; LOW DRUG DOSE; LUNG FUNCTION TEST; LYMPHADENOPATHY; LYMPHOCYTOSIS; MALE; MEDIASTINUM LYMPH NODE; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MULTIPLE SCLEROSIS; MYALGIA; NERVOUS SYSTEM TUMOR; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC CHIASM; ORGANIZING PNEUMONIA; ORTHOSTATIC HYPOTENSION; PARESTHESIA; PORTUGAL; POSTOPERATIVE COMPLICATION; PULMONARY HYPERTENSION; SARCOIDOSIS; SIDE EFFECT; SKIN BIOPSY; SKIN DEFECT; SKIN DISEASE; SKIN NODULE; SPLENECTOMY; SPLENOMEGALY; SUBCAPSULAR CATARACT; THORAX RADIOGRAPHY; THROMBOCYTOPENIA; VASCULAR LESION; VISUAL IMPAIRMENT; WEIGHT; WEIGHT GAIN; CASE REPORT; DRUG ANTAGONISM; FOLLOW UP; MIDDLE AGED;

ADULT; ANTIBODIES, MONOCLONAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PORTUGAL; SARCOIDOSIS, PULMONARY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80052178429     PISSN: 08732159     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0873-2159(11)70020-4     Document Type: Article

References (20)

1. Saleh S, Ghodsian S, Yakaimova V, Henderson J, Sharma OP. Effectiveness of Infliximab in treating selected patients with sarcoidosis. Respiratory Medicine. 2006;100:2053-9.
2. Callejas-Rubio JL, López-Pérez L, Ortego-Centeno N. Tumor necrosis factor-alpha inhibitor treatment for sarcoidosis. Therapeutics and Clinical Risk Management. 2008;4:1305-13.
3. Hunninghake G, Crystal R. Pulmonary sarcoidosis; a disorder mediated by excess T-helper lymphocyte activity at sites of disease activity. N Engl J Med. 1981;305:429-32.
4. Thomas P, Hunninghake G. Current concepts of the pathogenesis of sarcoidosis. Am Rev Respir Dis. 1987;135:747-60.
5. Targan SR, Hanauer SR, Van Deventer SJH, et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor a for Crohn's disease. N Engl J Med. 1997;337:1029-35.
6. Maksymowch W, Inman R, Gladman D, et al. Canadian rheumatology association consensus on the use of antitumor necrosis factor-alpha directed therapies in the treatment of spondyloarthritis. J Rheumatol. 2003;30:1356-63.
7. Antoni G, Krueger G, De Vlam K, et al. Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial. Ann Rheum Dis. 2005;64:1150-7.
8. Doty JD, Mazur JE, Judson MA. Treatment of sarcoidosis with Infliximab. Chest. 2005;127:1064-71.
9. Baughman R, Lower E. Infliximab in refractory sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2001;18:70-4.
10. Roberts S, Wilkes D, Burgett R, et al. Refractory sarcoidosis responding to Infliximab. Chest. 2003;124:2028-31.
11. Pettersen J, Zochodne D, Bell R, et al. Refractory neurosarcoidosis responding to Infliximab. Neurology. 2002;59:1660-1.
12. Maini RN, Breedveld FC, Kalden JR, et al. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor-alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum. 1998;41:1552-63.
13. Maini R, Breedveld F, Kalden J, et al. Low dose methotrexate suppresses antiglobulin responses and potentiates efficacy of a chimeric monoclonal anti-TNF-a antibody (cA2) given repeatedly in rheumatoid arthritis. Arthritis Rheum. 1997;40 Suppl:126.
14. Crum NF, Lederman ER, Wallace MR. Infections associated with tumor necrosis factor-a antagonists. Medicine. 2005;84:291-302.
15. Wood KL, Hage CA, Knox KS, et al. Histoplasmosis after treatment with anti-tumor necrosis factor-a therapy. Am J Respir Crit Care Med. 2003;167:1279-82.
16. Almodóvar R, Izquierdo M, Zarco P, Javier Quirós F, Mazzucchelli R, Steen B. Pulmonary sarcoidosis in a patient with ankylosing spondylitis treated with Infliximab. Clin Exp Rheumatol. 2007;25:99-101.
17. Rosen T, Doherty C. Successful long-term management of refractory cutaneous and upper airway sarcoidosis with periodic Infliximab infusion. Dermatol Online J. 2007;13:14.
18. Uthman I, Touma Z, Khoury M. Cardiac sarcoidosis responding to monotherapy with Infliximab. Clin Rheumatol. 2007;26:2001-3.
19. Kobylecki C, Shaunak S. Refractory neurosarcoidosis responsive to Infliximab. Pract Neurol. 2007;7:112-5.
20. Meyerle JH, Shorr A. The use of infliximab in cutaneous sarcoidosis. J Drugs Dermatol. 2003;2:413-4.